🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12444+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12444 recruiting trials

RecruitingNCT05937776

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

👨‍⚕️ Martin Pike, Ph.D., OHSU Knight Cancer Institute📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT05989698

Validation of the C-mo System - Cough Monitoring

👨‍⚕️ Nuno M Neuparth, PhD, NOVA Medical School | Faculdade de Ciências Médicas da Universidade Nova de Lisboa📍 8 sites📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT06067958

Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity

🏥 Assaf-Harofeh Medical Center📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT06070688

An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

👨‍⚕️ David Robinson, MD,MS,MMM, The University of Texas Health Science Center, Houston📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06163924

The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT

🏥 Chinese University of Hong Kong📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT06188650

The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study

🏥 Ningbo Medical Center Lihuili Hospital📍 1 site📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT05666700

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study

👨‍⚕️ Simon Harrison, Peter MacCallum Cancer Centre, Australia📍 1 site📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT06028373

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

🏥 Antengene Biologics Limited📍 4 sites📅 Started Dec 2023View details ↗
NARecruitingNCT05962827

Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY

👨‍⚕️ Verena FASSBENDER, Centre Hospitalier Universitaire de Nice📍 2 sites📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT05947344

A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)

🏥 Zhejiang ACEA Pharmaceutical Co. Ltd.📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT06872437

Evaluation of the Efficacy of Therapeutic Infiltrations of the Pudendal Nerve, Performed Under Neurostimulation on Pain, 1 Month After an Infiltration of Local Anaesthetic, in the Treatment of Pudendal Neuralgia.

👨‍⚕️ Axel EGAL, Doctor, Groupe Hospitalier Diaconesses Croix Saint-Simon📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06205927

Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer

👨‍⚕️ Jingfang Mao, PHD, Shanghai Proton and Heavy Ion Center📍 1 site📅 Started Dec 2023View details ↗
Phase 4RecruitingNCT05929729

Iron Deficiency Anemia (IDA) and the Brain

👨‍⚕️ John Wood, MD, PhD, Children's Hospital Los Angeles📍 4 sites📅 Started Dec 2023View details ↗
NARecruitingNCT05460611

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

👨‍⚕️ Kseniya Kobets, MD, Albert Einstein College of Medicine Montefiore Medical Center📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT06463925

Evaluation of Effaclar Duo+M on Acne Lesions in Subjects With Mild to Moderate Acne on Face and Trunk

👨‍⚕️ Renato Moura, Centre International de Développement Pharmaceutique (CIDP)📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05383742

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

🏥 National Institute of Allergy and Infectious Diseases (NIAID)📍 18 sites📅 Started Dec 2023View details ↗
NARecruitingNCT05930093

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

🏥 TCM Biotech International Corp.📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05440422

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

👨‍⚕️ Mariana J Kaplan, M.D., National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT06007690

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

👨‍⚕️ Medical Monitor, Aura Biosciences📍 71 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05956041

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

👨‍⚕️ Ryan Wilcox, University of Michigan Rogel Cancer Center📍 1 site📅 Started Dec 2023View details ↗
← PreviousPage 352 of 623Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →